Call TR, Pace NL, Thorup DB, et al. Factors associated with improved survival after resection of pancreatic adenocarcinoma: a multivariable model. Anesthesiology. 2015;122(2):317–24. https://doi.org/10.1097/aln.0000000000000489.

Article  PubMed  Google Scholar 

Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis. Cancer Lett. 2021;520:1–11. https://doi.org/10.1016/j.canlet.2021.06.027.

Article  PubMed  Google Scholar 

Karim SAM, Abdulla KS, Abdulkarim QH, Rahim FH. The outcomes and complications of pancreaticoduodenectomy (Whipple procedure): cross sectional study. Int J Surg. 2018;52:383–7. https://doi.org/10.1016/j.ijsu.2018.01.041.

Article  PubMed  Google Scholar 

Liu M, Ji S, Xu W, et al. Laparoscopic pancreaticoduodenectomy: are the best times coming? World J Surg Oncol. 2019;17(1):81. https://doi.org/10.1186/s12957-019-1624-6.

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Li H, Zhang J, et al. Dexamethasone or combined with others for postoperative nausea and vomiting in children: a systematic review. Asian J Surg. 2020;43(9):873–9. https://doi.org/10.1016/j.asjsur.2019.11.012.

Article  PubMed  Google Scholar 

Schorn S, Demir IE, Vogel T, et al. Mortality and postoperative complications after different types of surgical reconstruction following pancreaticoduodenectomy-a systematic review with meta-analysis. Langenbeck’s Arch Surg. 2019;404(2):141–57. https://doi.org/10.1007/s00423-019-01762-5.

Article  Google Scholar 

Kokkinakis S, Kritsotakis EI, Maliotis N, Karageorgiou I, Chrysos E, Lasithiotakis K. Complications of modern pancreaticoduodenectomy: a systematic review and meta-analysis. Hepatobiliary Pancreatic Dis Int. 2022;21(6):527–37. https://doi.org/10.1016/j.hbpd.2022.04.006.

Article  Google Scholar 

Mintziras I, Wächter S, Manoharan J, Kanngiesser V, Maurer E, Bartsch DK. Postoperative morbidity following pancreatic cancer surgery is significantly associated with worse overall patient survival; systematic review and meta-analysis. Surg Oncol. 2021;38:101573. https://doi.org/10.1016/j.suronc.2021.101573.

Article  PubMed  Google Scholar 

Sinner B. Perioperatives dexamethason. Der Anaesthesist. 2019;68(10):676–82. https://doi.org/10.1007/s00101-019-00672-x.

Article  PubMed  Google Scholar 

Czarnetzki C, Albrecht E, Desmeules J, et al. Dexamethasone for the treatment of established postoperative nausea and vomiting: a randomised dose finding trial. Eur J Anaesthesiol. 2022;39(6):549–57.

Article  PubMed  Google Scholar 

Mauermann E, Clamer D, Ruppen W, Bandschapp O. Association between intra-operative fentanyl dosing and postoperative nausea/vomiting and pain: a prospective cohort study. Eur J Anaesthesiol. 2019;36(11):871–80. https://doi.org/10.1097/eja.0000000000001081.

Article  PubMed  Google Scholar 

Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesthesia Analgesia. 2020;131(2):411–48. https://doi.org/10.1213/ane.0000000000004833.

Article  PubMed  Google Scholar 

Polderman JAW, Farhang-Razi V, van Dieren S, et al. Adverse side-effects of dexamethasone in surgical patients - an abridged Cochrane systematic review. Anaesthesia. 2019;74(7):929–39. https://doi.org/10.1111/anae.14610.

Article  PubMed  Google Scholar 

Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair and regeneration. Science (New York, NY). 2017;356(6342):1026–30. https://doi.org/10.1126/science.aam7928.

Article  Google Scholar 

Rodrigues M, Kosaric N, Bonham CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev. 2019;99(1):665–706. https://doi.org/10.1152/physrev.00067.2017.

Article  PubMed  Google Scholar 

Bortolotti P, Delpierre C, Le Guern R, et al. High incidence of postoperative infections after pancreaticoduodenectomy: a need for perioperative anti-infectious strategies. Infect Dis Now. 2021;51(5):456–63. https://doi.org/10.1016/j.idnow.2021.01.001.

Article  PubMed  Google Scholar 

Kuan LL, Dennison AR, Garcea G. Outcomes of peri-operative glucocorticosteroid use in major pancreatic resections: a systematic review. HPB (Oxford). 2021;23(12):1789–98. https://doi.org/10.1016/j.hpb.2021.07.001.

Article  PubMed  Google Scholar 

Laaninen M, Sand J, Nordback I, Vasama K, Laukkarinen J. Perioperative hydrocortisone reduces major complications after pancreaticoduodenectomy: a randomized controlled trial. Ann Surg. 2016;264(5):696–702.

Article  PubMed  Google Scholar 

Chen H, Wang Y, Jiang K, et al. The effect of perioperative dexamethasone on postoperative complications after pancreaticoduodenectomy: a multicenter randomized controlled trial. Ann Surg. 2024;280(2):222–8. https://doi.org/10.1097/sla.0000000000006240.

Article  PubMed  Google Scholar 

Newhook TE, Soliz JM, Prakash LR, et al. Impact of intraoperative dexamethasone on surgical and oncologic outcomes for patients with resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2020;28(3):1563–9. https://doi.org/10.1245/s10434-020-09013-4.

Article  PubMed  Google Scholar 

Sandini M, Ruscic KJ, Ferrone CR, et al. Intraoperative dexamethasone decreases infectious complications after pancreaticoduodenectomy and is associated with long-term survival in pancreatic cancer. Ann Surg Oncol. 2018;25(13):4020–6. https://doi.org/10.1245/s10434-018-6827-5.

Article  PubMed  Google Scholar 

Kant K, Ahmed Z, Dama R, et al. Does perioperative hydrocortisone or indomethacin improve pancreatoduodenectomy outcomes? A triple arm, randomized placebo-controlled trial. Ann Hepato-Biliary-Pancreatic Surg. 2024. https://doi.org/10.14701/ahbps.24-021.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372:n71. https://doi.org/10.1136/bmj.n71.

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906.

Article  PubMed  Google Scholar 

Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250(2):177–86. https://doi.org/10.1097/SLA.0b013e3181afde41.

Article  PubMed  Google Scholar 

Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142(5):761–8. https://doi.org/10.1016/j.surg.2007.05.005.

Article  PubMed  Google Scholar 

Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–91. https://doi.org/10.1016/j.surg.2016.11.014.

Article  PubMed  Google Scholar 

Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Annals of Surgery. 2009;250(2):187–96.

Article  PubMed  Google Scholar 

Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res Ed). 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.

Article  Google Scholar 

Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed). 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

Article  Google Scholar 

Yoshioka R, Yasunaga H, Hasegawa K, et al. Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy. Br J Surg. 2014;101(5):523–9. https://doi.org/10.1002/bjs.9420.

Article  PubMed  Google Scholar 

Jiang J, Upfill-Brown A, Dann AM, et al. Association of hospital length of stay and complications with readmission after open pancreaticoduodenectomy. JAMA Surg. 2019;154(1):88–90. https://doi.org/10.1001/jamasurg.2018.3213.

Article  PubMed  Google Scholar 

Zhang YX, Mu DL, Jin KM, Li XY, Wang DX. Perioperative glucocorticoids are associated with improved recurrence-free survival after pancreatic cancer surgery: a retrospective cohort study with propensity score-matching. Therapeut Clin Risk Manag. 2021;17:87–101. https://doi.org/10.2147/tcrm.s287572.